nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—AHR—Leflunomide—systemic scleroderma	0.698	0.867	CbGbCtD
Mexiletine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0342	0.0425	CbGbCtD
Mexiletine—CYP1A2—Leflunomide—systemic scleroderma	0.0326	0.0405	CbGbCtD
Mexiletine—CYP2D6—Captopril—systemic scleroderma	0.0211	0.0262	CbGbCtD
Mexiletine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0106	0.0131	CbGbCtD
Mexiletine—CYP3A4—Prednisone—systemic scleroderma	0.00845	0.0105	CbGbCtD
Mexiletine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000294	0.00151	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000294	0.00151	CcSEcCtD
Mexiletine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000293	0.0015	CcSEcCtD
Mexiletine—Abdominal pain—Captopril—systemic scleroderma	0.000292	0.0015	CcSEcCtD
Mexiletine—Body temperature increased—Captopril—systemic scleroderma	0.000292	0.0015	CcSEcCtD
Mexiletine—Oedema—Mycophenolic acid—systemic scleroderma	0.000291	0.00149	CcSEcCtD
Mexiletine—Dry skin—Prednisone—systemic scleroderma	0.00029	0.00149	CcSEcCtD
Mexiletine—Nausea—Pentoxifylline—systemic scleroderma	0.00029	0.00149	CcSEcCtD
Mexiletine—Malaise—Lisinopril—systemic scleroderma	0.000289	0.00149	CcSEcCtD
Mexiletine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000288	0.00148	CcSEcCtD
Mexiletine—Diarrhoea—Mometasone—systemic scleroderma	0.000288	0.00148	CcSEcCtD
Mexiletine—Syncope—Lisinopril—systemic scleroderma	0.000288	0.00148	CcSEcCtD
Mexiletine—Leukopenia—Lisinopril—systemic scleroderma	0.000287	0.00147	CcSEcCtD
Mexiletine—Shock—Mycophenolic acid—systemic scleroderma	0.000286	0.00147	CcSEcCtD
Mexiletine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00146	CcSEcCtD
Mexiletine—Hypotension—Leflunomide—systemic scleroderma	0.000285	0.00146	CcSEcCtD
Mexiletine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000284	0.00146	CcSEcCtD
Mexiletine—Palpitations—Lisinopril—systemic scleroderma	0.000283	0.00146	CcSEcCtD
Mexiletine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000282	0.00145	CcSEcCtD
Mexiletine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000281	0.00144	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00028	0.00144	CcSEcCtD
Mexiletine—Visual disturbance—Methotrexate—systemic scleroderma	0.000279	0.00143	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000277	0.00143	CcSEcCtD
Mexiletine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000276	0.00142	CcSEcCtD
Mexiletine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.00141	CcSEcCtD
Mexiletine—Paraesthesia—Leflunomide—systemic scleroderma	0.000273	0.0014	CcSEcCtD
Mexiletine—Arthralgia—Lisinopril—systemic scleroderma	0.000273	0.0014	CcSEcCtD
Mexiletine—Chest pain—Lisinopril—systemic scleroderma	0.000273	0.0014	CcSEcCtD
Mexiletine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000273	0.0014	CcSEcCtD
Mexiletine—Dyspnoea—Leflunomide—systemic scleroderma	0.000272	0.00139	CcSEcCtD
Mexiletine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000272	0.00139	CcSEcCtD
Mexiletine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00139	CcSEcCtD
Mexiletine—Discomfort—Lisinopril—systemic scleroderma	0.00027	0.00139	CcSEcCtD
Mexiletine—Dyspepsia—Leflunomide—systemic scleroderma	0.000268	0.00138	CcSEcCtD
Mexiletine—Pancreatitis—Prednisone—systemic scleroderma	0.000268	0.00138	CcSEcCtD
Mexiletine—Vomiting—Mometasone—systemic scleroderma	0.000268	0.00137	CcSEcCtD
Mexiletine—Dry mouth—Lisinopril—systemic scleroderma	0.000267	0.00137	CcSEcCtD
Mexiletine—Sweating increased—Prednisone—systemic scleroderma	0.000266	0.00137	CcSEcCtD
Mexiletine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000266	0.00137	CcSEcCtD
Mexiletine—Rash—Mometasone—systemic scleroderma	0.000265	0.00136	CcSEcCtD
Mexiletine—Asthenia—Captopril—systemic scleroderma	0.000265	0.00136	CcSEcCtD
Mexiletine—Dermatitis—Mometasone—systemic scleroderma	0.000265	0.00136	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000265	0.00136	CcSEcCtD
Mexiletine—Confusional state—Lisinopril—systemic scleroderma	0.000264	0.00136	CcSEcCtD
Mexiletine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000264	0.00135	CcSEcCtD
Mexiletine—Headache—Mometasone—systemic scleroderma	0.000264	0.00135	CcSEcCtD
Mexiletine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00135	CcSEcCtD
Mexiletine—Fatigue—Leflunomide—systemic scleroderma	0.000263	0.00135	CcSEcCtD
Mexiletine—Oedema—Lisinopril—systemic scleroderma	0.000262	0.00134	CcSEcCtD
Mexiletine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000261	0.00134	CcSEcCtD
Mexiletine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000261	0.00134	CcSEcCtD
Mexiletine—Pain—Leflunomide—systemic scleroderma	0.00026	0.00134	CcSEcCtD
Mexiletine—Constipation—Leflunomide—systemic scleroderma	0.00026	0.00134	CcSEcCtD
Mexiletine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000259	0.00133	CcSEcCtD
Mexiletine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000258	0.00133	CcSEcCtD
Mexiletine—Shock—Lisinopril—systemic scleroderma	0.000257	0.00132	CcSEcCtD
Mexiletine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000256	0.00132	CcSEcCtD
Mexiletine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000256	0.00131	CcSEcCtD
Mexiletine—Neutropenia—Prednisone—systemic scleroderma	0.000256	0.00131	CcSEcCtD
Mexiletine—Abdominal pain—Azathioprine—systemic scleroderma	0.000255	0.00131	CcSEcCtD
Mexiletine—Body temperature increased—Azathioprine—systemic scleroderma	0.000255	0.00131	CcSEcCtD
Mexiletine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000253	0.0013	CcSEcCtD
Mexiletine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000253	0.0013	CcSEcCtD
Mexiletine—Diarrhoea—Captopril—systemic scleroderma	0.000253	0.0013	CcSEcCtD
Mexiletine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00129	CcSEcCtD
Mexiletine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000252	0.00129	CcSEcCtD
Mexiletine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00129	CcSEcCtD
Mexiletine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000251	0.00129	CcSEcCtD
Mexiletine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000251	0.00129	CcSEcCtD
Mexiletine—Nausea—Mometasone—systemic scleroderma	0.00025	0.00128	CcSEcCtD
Mexiletine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000249	0.00128	CcSEcCtD
Mexiletine—Ataxia—Methotrexate—systemic scleroderma	0.000249	0.00128	CcSEcCtD
Mexiletine—Pain—Mycophenolic acid—systemic scleroderma	0.000248	0.00128	CcSEcCtD
Mexiletine—Constipation—Mycophenolic acid—systemic scleroderma	0.000248	0.00128	CcSEcCtD
Mexiletine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000248	0.00128	CcSEcCtD
Mexiletine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00127	CcSEcCtD
Mexiletine—Hypotension—Lisinopril—systemic scleroderma	0.000245	0.00126	CcSEcCtD
Mexiletine—Dizziness—Captopril—systemic scleroderma	0.000244	0.00126	CcSEcCtD
Mexiletine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000244	0.00125	CcSEcCtD
Mexiletine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00125	CcSEcCtD
Mexiletine—Depression—Prednisone—systemic scleroderma	0.000243	0.00125	CcSEcCtD
Mexiletine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00125	CcSEcCtD
Mexiletine—Body temperature increased—Leflunomide—systemic scleroderma	0.000241	0.00124	CcSEcCtD
Mexiletine—Abdominal pain—Leflunomide—systemic scleroderma	0.000241	0.00124	CcSEcCtD
Mexiletine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000239	0.00123	CcSEcCtD
Mexiletine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00123	CcSEcCtD
Mexiletine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00123	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000238	0.00122	CcSEcCtD
Mexiletine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000238	0.00122	CcSEcCtD
Mexiletine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000238	0.00122	CcSEcCtD
Mexiletine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000236	0.00121	CcSEcCtD
Mexiletine—Paraesthesia—Lisinopril—systemic scleroderma	0.000235	0.00121	CcSEcCtD
Mexiletine—Vomiting—Captopril—systemic scleroderma	0.000235	0.00121	CcSEcCtD
Mexiletine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000234	0.0012	CcSEcCtD
Mexiletine—Dyspnoea—Lisinopril—systemic scleroderma	0.000233	0.0012	CcSEcCtD
Mexiletine—Rash—Captopril—systemic scleroderma	0.000233	0.0012	CcSEcCtD
Mexiletine—Dermatitis—Captopril—systemic scleroderma	0.000233	0.0012	CcSEcCtD
Mexiletine—Somnolence—Lisinopril—systemic scleroderma	0.000233	0.0012	CcSEcCtD
Mexiletine—Headache—Captopril—systemic scleroderma	0.000232	0.00119	CcSEcCtD
Mexiletine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000231	0.00119	CcSEcCtD
Mexiletine—Dyspepsia—Lisinopril—systemic scleroderma	0.00023	0.00118	CcSEcCtD
Mexiletine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00023	0.00118	CcSEcCtD
Mexiletine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00023	0.00118	CcSEcCtD
Mexiletine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00118	CcSEcCtD
Mexiletine—Fatigue—Lisinopril—systemic scleroderma	0.000226	0.00116	CcSEcCtD
Mexiletine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000226	0.00116	CcSEcCtD
Mexiletine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000225	0.00115	CcSEcCtD
Mexiletine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000224	0.00115	CcSEcCtD
Mexiletine—Pancreatitis—Methotrexate—systemic scleroderma	0.000224	0.00115	CcSEcCtD
Mexiletine—Constipation—Lisinopril—systemic scleroderma	0.000224	0.00115	CcSEcCtD
Mexiletine—Pain—Lisinopril—systemic scleroderma	0.000224	0.00115	CcSEcCtD
Mexiletine—Bradycardia—Prednisone—systemic scleroderma	0.000223	0.00114	CcSEcCtD
Mexiletine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00114	CcSEcCtD
Mexiletine—Diarrhoea—Azathioprine—systemic scleroderma	0.000221	0.00113	CcSEcCtD
Mexiletine—Nausea—Captopril—systemic scleroderma	0.00022	0.00113	CcSEcCtD
Mexiletine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000219	0.00112	CcSEcCtD
Mexiletine—Asthenia—Leflunomide—systemic scleroderma	0.000219	0.00112	CcSEcCtD
Mexiletine—Hallucination—Prednisone—systemic scleroderma	0.000218	0.00112	CcSEcCtD
Mexiletine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000216	0.00111	CcSEcCtD
Mexiletine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000214	0.0011	CcSEcCtD
Mexiletine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000214	0.0011	CcSEcCtD
Mexiletine—Neutropenia—Methotrexate—systemic scleroderma	0.000214	0.0011	CcSEcCtD
Mexiletine—Dizziness—Azathioprine—systemic scleroderma	0.000213	0.0011	CcSEcCtD
Mexiletine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00021	0.00108	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000209	0.00107	CcSEcCtD
Mexiletine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000208	0.00107	CcSEcCtD
Mexiletine—Diarrhoea—Leflunomide—systemic scleroderma	0.000208	0.00107	CcSEcCtD
Mexiletine—Abdominal pain—Lisinopril—systemic scleroderma	0.000207	0.00106	CcSEcCtD
Mexiletine—Body temperature increased—Lisinopril—systemic scleroderma	0.000207	0.00106	CcSEcCtD
Mexiletine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00106	CcSEcCtD
Mexiletine—Vomiting—Azathioprine—systemic scleroderma	0.000205	0.00105	CcSEcCtD
Mexiletine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00105	CcSEcCtD
Mexiletine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00105	CcSEcCtD
Mexiletine—Drowsiness—Methotrexate—systemic scleroderma	0.000204	0.00105	CcSEcCtD
Mexiletine—Rash—Azathioprine—systemic scleroderma	0.000203	0.00104	CcSEcCtD
Mexiletine—Dermatitis—Azathioprine—systemic scleroderma	0.000203	0.00104	CcSEcCtD
Mexiletine—Depression—Methotrexate—systemic scleroderma	0.000203	0.00104	CcSEcCtD
Mexiletine—Headache—Azathioprine—systemic scleroderma	0.000202	0.00104	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000202	0.00104	CcSEcCtD
Mexiletine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000202	0.00104	CcSEcCtD
Mexiletine—Dizziness—Leflunomide—systemic scleroderma	0.000201	0.00103	CcSEcCtD
Mexiletine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000199	0.00102	CcSEcCtD
Mexiletine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000196	0.00101	CcSEcCtD
Mexiletine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000196	0.00101	CcSEcCtD
Mexiletine—Arrhythmia—Prednisone—systemic scleroderma	0.000195	0.001	CcSEcCtD
Mexiletine—Vomiting—Leflunomide—systemic scleroderma	0.000194	0.000995	CcSEcCtD
Mexiletine—Alopecia—Prednisone—systemic scleroderma	0.000193	0.000993	CcSEcCtD
Mexiletine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000193	0.00099	CcSEcCtD
Mexiletine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000192	0.000987	CcSEcCtD
Mexiletine—Rash—Leflunomide—systemic scleroderma	0.000192	0.000986	CcSEcCtD
Mexiletine—Dermatitis—Leflunomide—systemic scleroderma	0.000192	0.000986	CcSEcCtD
Mexiletine—Nausea—Azathioprine—systemic scleroderma	0.000192	0.000984	CcSEcCtD
Mexiletine—Headache—Leflunomide—systemic scleroderma	0.000191	0.00098	CcSEcCtD
Mexiletine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00019	0.000976	CcSEcCtD
Mexiletine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000971	CcSEcCtD
Mexiletine—Asthenia—Lisinopril—systemic scleroderma	0.000188	0.000965	CcSEcCtD
Mexiletine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000963	CcSEcCtD
Mexiletine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000185	0.000949	CcSEcCtD
Mexiletine—Rash—Mycophenolic acid—systemic scleroderma	0.000183	0.000941	CcSEcCtD
Mexiletine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000183	0.00094	CcSEcCtD
Mexiletine—Hepatitis—Methotrexate—systemic scleroderma	0.000183	0.000939	CcSEcCtD
Mexiletine—Headache—Mycophenolic acid—systemic scleroderma	0.000182	0.000935	CcSEcCtD
Mexiletine—Pharyngitis—Methotrexate—systemic scleroderma	0.000181	0.000932	CcSEcCtD
Mexiletine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000931	CcSEcCtD
Mexiletine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000931	CcSEcCtD
Mexiletine—Nausea—Leflunomide—systemic scleroderma	0.000181	0.000929	CcSEcCtD
Mexiletine—Vision blurred—Prednisone—systemic scleroderma	0.000179	0.000922	CcSEcCtD
Mexiletine—Diarrhoea—Lisinopril—systemic scleroderma	0.000179	0.00092	CcSEcCtD
Mexiletine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000177	0.000908	CcSEcCtD
Mexiletine—Visual impairment—Methotrexate—systemic scleroderma	0.000176	0.000905	CcSEcCtD
Mexiletine—Dizziness—Lisinopril—systemic scleroderma	0.000173	0.000889	CcSEcCtD
Mexiletine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000173	0.000888	CcSEcCtD
Mexiletine—Nausea—Mycophenolic acid—systemic scleroderma	0.000173	0.000887	CcSEcCtD
Mexiletine—Malaise—Prednisone—systemic scleroderma	0.000172	0.000882	CcSEcCtD
Mexiletine—Syncope—Prednisone—systemic scleroderma	0.000171	0.000877	CcSEcCtD
Mexiletine—Tinnitus—Methotrexate—systemic scleroderma	0.00017	0.000876	CcSEcCtD
Mexiletine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000868	CcSEcCtD
Mexiletine—Loss of consciousness—Prednisone—systemic scleroderma	0.000167	0.00086	CcSEcCtD
Mexiletine—Vomiting—Lisinopril—systemic scleroderma	0.000166	0.000855	CcSEcCtD
Mexiletine—Rash—Lisinopril—systemic scleroderma	0.000165	0.000848	CcSEcCtD
Mexiletine—Convulsion—Prednisone—systemic scleroderma	0.000165	0.000848	CcSEcCtD
Mexiletine—Dermatitis—Lisinopril—systemic scleroderma	0.000165	0.000847	CcSEcCtD
Mexiletine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000845	CcSEcCtD
Mexiletine—Hypertension—Prednisone—systemic scleroderma	0.000164	0.000845	CcSEcCtD
Mexiletine—Headache—Lisinopril—systemic scleroderma	0.000164	0.000842	CcSEcCtD
Mexiletine—Arthralgia—Prednisone—systemic scleroderma	0.000162	0.000833	CcSEcCtD
Mexiletine—Alopecia—Methotrexate—systemic scleroderma	0.000162	0.00083	CcSEcCtD
Mexiletine—Discomfort—Prednisone—systemic scleroderma	0.00016	0.000823	CcSEcCtD
Mexiletine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000806	CcSEcCtD
Mexiletine—Dysgeusia—Methotrexate—systemic scleroderma	0.000156	0.000801	CcSEcCtD
Mexiletine—Nausea—Lisinopril—systemic scleroderma	0.000155	0.000798	CcSEcCtD
Mexiletine—Oedema—Prednisone—systemic scleroderma	0.000155	0.000798	CcSEcCtD
Mexiletine—Shock—Prednisone—systemic scleroderma	0.000153	0.000785	CcSEcCtD
Mexiletine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000779	CcSEcCtD
Mexiletine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00015	0.000772	CcSEcCtD
Mexiletine—Vision blurred—Methotrexate—systemic scleroderma	0.00015	0.000771	CcSEcCtD
Mexiletine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000148	0.000759	CcSEcCtD
Mexiletine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000749	CcSEcCtD
Mexiletine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000743	CcSEcCtD
Mexiletine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000742	CcSEcCtD
Mexiletine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000738	CcSEcCtD
Mexiletine—Malaise—Methotrexate—systemic scleroderma	0.000144	0.000737	CcSEcCtD
Mexiletine—Leukopenia—Methotrexate—systemic scleroderma	0.000142	0.000732	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000142	0.000727	CcSEcCtD
Mexiletine—Paraesthesia—Prednisone—systemic scleroderma	0.00014	0.000717	CcSEcCtD
Mexiletine—Convulsion—Methotrexate—systemic scleroderma	0.000138	0.000708	CcSEcCtD
Mexiletine—Dyspepsia—Prednisone—systemic scleroderma	0.000137	0.000703	CcSEcCtD
Mexiletine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000136	0.0007	CcSEcCtD
Mexiletine—Arthralgia—Methotrexate—systemic scleroderma	0.000136	0.000696	CcSEcCtD
Mexiletine—Chest pain—Methotrexate—systemic scleroderma	0.000136	0.000696	CcSEcCtD
Mexiletine—Fatigue—Prednisone—systemic scleroderma	0.000134	0.000688	CcSEcCtD
Mexiletine—Discomfort—Methotrexate—systemic scleroderma	0.000134	0.000688	CcSEcCtD
Mexiletine—Constipation—Prednisone—systemic scleroderma	0.000133	0.000683	CcSEcCtD
Mexiletine—Confusional state—Methotrexate—systemic scleroderma	0.000131	0.000673	CcSEcCtD
Mexiletine—Feeling abnormal—Prednisone—systemic scleroderma	0.000128	0.000658	CcSEcCtD
Mexiletine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000127	0.000653	CcSEcCtD
Mexiletine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000127	0.000653	CcSEcCtD
Mexiletine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000126	0.000645	CcSEcCtD
Mexiletine—Abdominal pain—Prednisone—systemic scleroderma	0.000123	0.000631	CcSEcCtD
Mexiletine—Body temperature increased—Prednisone—systemic scleroderma	0.000123	0.000631	CcSEcCtD
Mexiletine—Hypotension—Methotrexate—systemic scleroderma	0.000121	0.000623	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000118	0.000608	CcSEcCtD
Mexiletine—Paraesthesia—Methotrexate—systemic scleroderma	0.000117	0.000599	CcSEcCtD
Mexiletine—Dyspnoea—Methotrexate—systemic scleroderma	0.000116	0.000595	CcSEcCtD
Mexiletine—Somnolence—Methotrexate—systemic scleroderma	0.000115	0.000593	CcSEcCtD
Mexiletine—Hypersensitivity—Prednisone—systemic scleroderma	0.000115	0.000588	CcSEcCtD
Mexiletine—Dyspepsia—Methotrexate—systemic scleroderma	0.000114	0.000587	CcSEcCtD
Mexiletine—Fatigue—Methotrexate—systemic scleroderma	0.000112	0.000575	CcSEcCtD
Mexiletine—Asthenia—Prednisone—systemic scleroderma	0.000112	0.000573	CcSEcCtD
Mexiletine—Pain—Methotrexate—systemic scleroderma	0.000111	0.000571	CcSEcCtD
Mexiletine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000107	0.00055	CcSEcCtD
Mexiletine—Diarrhoea—Prednisone—systemic scleroderma	0.000106	0.000546	CcSEcCtD
Mexiletine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000106	0.000546	CcSEcCtD
Mexiletine—Dizziness—Prednisone—systemic scleroderma	0.000103	0.000528	CcSEcCtD
Mexiletine—Abdominal pain—Methotrexate—systemic scleroderma	0.000103	0.000527	CcSEcCtD
Mexiletine—Body temperature increased—Methotrexate—systemic scleroderma	0.000103	0.000527	CcSEcCtD
Mexiletine—Vomiting—Prednisone—systemic scleroderma	9.88e-05	0.000508	CcSEcCtD
Mexiletine—Rash—Prednisone—systemic scleroderma	9.8e-05	0.000503	CcSEcCtD
Mexiletine—Dermatitis—Prednisone—systemic scleroderma	9.79e-05	0.000503	CcSEcCtD
Mexiletine—Headache—Prednisone—systemic scleroderma	9.74e-05	0.0005	CcSEcCtD
Mexiletine—Hypersensitivity—Methotrexate—systemic scleroderma	9.57e-05	0.000492	CcSEcCtD
Mexiletine—Asthenia—Methotrexate—systemic scleroderma	9.32e-05	0.000479	CcSEcCtD
Mexiletine—Nausea—Prednisone—systemic scleroderma	9.23e-05	0.000474	CcSEcCtD
Mexiletine—Diarrhoea—Methotrexate—systemic scleroderma	8.89e-05	0.000457	CcSEcCtD
Mexiletine—Dizziness—Methotrexate—systemic scleroderma	8.59e-05	0.000441	CcSEcCtD
Mexiletine—Vomiting—Methotrexate—systemic scleroderma	8.26e-05	0.000424	CcSEcCtD
Mexiletine—Rash—Methotrexate—systemic scleroderma	8.19e-05	0.000421	CcSEcCtD
Mexiletine—Dermatitis—Methotrexate—systemic scleroderma	8.18e-05	0.00042	CcSEcCtD
Mexiletine—Headache—Methotrexate—systemic scleroderma	8.14e-05	0.000418	CcSEcCtD
Mexiletine—Nausea—Methotrexate—systemic scleroderma	7.72e-05	0.000396	CcSEcCtD
